Sign Out
Rheumatoid arthritis: Baricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. Baricitinib may be used as monotherapy or in combination with methotrexate (see Precautions, Interactions, and Pharmacology: Pharmacodynamics under Actions for available data on different combinations).
Atopic dermatitis: Baricitinib is indicated for the treatment of moderate to severe atopic dermatitis in adult patients who are candidates for systemic therapy.
Alopecia areata: Baricitinib is indicated for the treatment of severe alopecia areata in adult patients (see Pharmacology: Pharmacodynamics under Actions).
